ABL Bio Inc. (KOSDAQ:298380)
173,400
+7,400 (4.46%)
At close: Nov 26, 2025
522.62% (1Y)
| Market Cap | 9.56T |
| Revenue (ttm) | 88.44B |
| Net Income (ttm) | -28.65B |
| Shares Out | 55.13M |
| EPS (ttm) | -575.91 |
| PE Ratio | n/a |
| Forward PE | 656.20 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 845,167 |
| Average Volume | 1,709,459 |
| Open | 169,200 |
| Previous Close | 166,000 |
| Day's Range | 167,000 - 173,500 |
| 52-Week Range | 25,950 - 195,500 |
| Beta | 0.74 |
| RSI | 71.34 |
| Earnings Date | Nov 10, 2025 |